MEBENDAZOLE Patent for Treatment of CANCER Mebendazole is sometimes...
William Makis@MakisMedicine
10 views
May 10, 2026
~1 min read
Advertisement
1
MEBENDAZOLE Patent for Treatment of CANCER
Mebendazole is sometimes called an “animal dewormer” like Ivermectin and Fenbendazole.
On Sep.7, 2021, Johns Hopkins University in Baltimore, MD secured a patent for MEBENDAZOLE for this use:
1. Repurposed for Glioblastoma Therapy
(as an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations)
2. Mebendazole may also be used for therapy of other cancers, as well as a chemo-preventative agent.
Patent No. US 11,110,079 B2
Date of Patent: Sep.7, 2021
The title of the patent: “Mebendazole Polymorph for Treatment and Prevention of Tumors”
Applicant: Johns Hopkins University
Inventors: Gregory Riggins, et al
I will let this sink in.
This is what I have been working with for the past 2 years, in the largest Ivermectin Cancer Project in the world. 9000+ Cancer patients.
You have never seen this patent in the news.
You have never seen any Oncologist talk about this patent.
Yet, this is a game changer for Glioblastoma Cancer patients.
Mebendazole is sometimes called an “animal dewormer” like Ivermectin and Fenbendazole.
On Sep.7, 2021, Johns Hopkins University in Baltimore, MD secured a patent for MEBENDAZOLE for this use:
1. Repurposed for Glioblastoma Therapy
(as an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations)
2. Mebendazole may also be used for therapy of other cancers, as well as a chemo-preventative agent.
Patent No. US 11,110,079 B2
Date of Patent: Sep.7, 2021
The title of the patent: “Mebendazole Polymorph for Treatment and Prevention of Tumors”
Applicant: Johns Hopkins University
Inventors: Gregory Riggins, et al
I will let this sink in.
This is what I have been working with for the past 2 years, in the largest Ivermectin Cancer Project in the world. 9000+ Cancer patients.
You have never seen this patent in the news.
You have never seen any Oncologist talk about this patent.
Yet, this is a game changer for Glioblastoma Cancer patients.